Up-regulation of FGF8 and FGFR3 was observed in CRC cells and xenografts receiving irinotecan-based chemotherapy, which led to induction of chemotherapy resistance (Erdem et al. 2017). The gene discussed is FGFR3; the disease is colorectal carcinoma.